In clinical trials, CTCAE is used to monitor and report adverse events in a standardized way. Investigators use CTCAE to document the type and severity of adverse events, which are then reported to regulatory agencies, ethics committees, and other stakeholders. This helps in evaluating the risk-benefit ratio of new treatments.
